NHLTY — Nightingale Health Share Price
Last trade - 00:00- $120.88m
- $64.59m
- €4.69m
- 57
- 22
- 55
- 41
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.55 | ||
| Price to Tang. Book | 1.8 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 21.8 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -28.43% | ||
| Return on Equity | -24.77% | ||
| Operating Margin | -413.74% | ||
Financial Summary
| Year End 30th Jun | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 2.31 | 2.31 | 4.18 | 4.36 | 4.69 | 8 | 9 | 21.38% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Nightingale Health Oyj is a Finland-based health technology company whose mission is to build sustainable healthcare and reduce health inequalities. It has developed an advanced health check that provides risk detection for multiple chronic diseases from a single blood sample. The blood analysis technology developed by Nightingale measures a broad group of biomarkers from a single blood sample, recognizing individual disease risks. The Company provides people with comprehensive insights on health, helps them make better decisions regarding their health and connects them with healthcare experts that offer preventative services for maintaining health. Nightingale Health Oy is the Parent Company in the Nightingale Group. The Company has subsidiaries in the United Kingdom, Japan, Sweden, Germany, Singapore, Estonia and the United States.
Directors
- Last Annual
- June 30th, 2025
- Last Interim
- June 30th, 2025
- Incorporated
- March 28th, 2002
- Public Since
- March 19th, 2021
- No. of Shareholders
- 12,930
- No. of Employees
- 100
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 60,441,663
- Address
- Mannerheimintie 164a, HELSINKI, 00300
- Web
- https://nightingalehealth.com/
- Phone
- +358 207301810
- Auditors
- PricewaterhouseCoopers Oy
Similar to NHLTY
Actavia Life Sciences
Pink Sheets on Nasdaq
Acura Pharmaceuticals
Pink Sheets on Nasdaq
Adhera Therapeutics
Pink Sheets on Nasdaq
Ramoil Management
Pink Sheets on Nasdaq
Adynxx
Pink Sheets on Nasdaq
FAQ
As of Today at 21:18 UTC, shares in Nightingale Health are trading at $2.00. This share price information is delayed by 15 minutes.
Shares in Nightingale Health last closed at $2.00 and the price had moved by over the past 365 days. In terms of relative price strength the Nightingale Health share price has matched the S&P500 Index by over the past year.
The overall consensus recommendation for Nightingale Health is Strong Sell. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreNightingale Health does not currently pay a dividend.
Nightingale Health does not currently pay a dividend.
Nightingale Health does not currently pay a dividend.
To buy shares in Nightingale Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $2.00, shares in Nightingale Health had a market capitalisation of $120.88m.
Here are the trading details for Nightingale Health:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: NHLTY
Based on an overall assessment of its quality, value and momentum Nightingale Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Nightingale Health is $2.13. That is 6.34% above the last closing price of $2.00.
Analysts covering Nightingale Health currently have a consensus Earnings Per Share (EPS) forecast of -€0.27 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nightingale Health. Over the past six months, its share price has matched the S&P500 Index by .
As of the last closing price of $2.00, shares in Nightingale Health were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Nightingale Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Nightingale Health's directors